Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1999 | 03-1999 | 12-1998 | 09-1998 | 06-1998 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,820 | -15,780 | -56,070 | -39,780 | -22,220 |
| Depreciation Amortization | 1,650 | 780 | 2,750 | 2,060 | 1,380 |
| Other Working Capital | -11,120 | -2,250 | 6,160 | 7,290 | 8,350 |
| Other Operating Activity | 0 | -10 | 440 | 10 | 0 |
| Operating Cash Flow | $-40,290 | $-17,260 | $-46,720 | $-30,420 | $-12,490 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,870 | -2,700 | -2,490 | -1,380 | -1,050 |
| Other Investing Activity | 50,760 | 41,450 | 42,530 | 38,400 | 14,520 |
| Investing Cash Flow | $46,890 | $38,750 | $40,040 | $37,020 | $13,470 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 6,260 | 4,480 | 7,160 | 4,570 | 4,050 |
| Financing Cash Flow | $6,260 | $4,480 | $7,160 | $4,570 | $4,050 |
| Beginning Cash Position | 32,470 | 32,470 | 31,990 | 31,990 | 31,990 |
| End Cash Position | 45,330 | 58,440 | 32,470 | 43,160 | 37,020 |
| Net Cash Flow | $12,860 | $25,970 | $480 | $11,170 | $5,030 |
| Free Cash Flow | |||||
| Operating Cash Flow | -40,290 | -17,260 | -46,720 | -30,420 | -12,490 |
| Free Cash Flow | -40,290 | -17,260 | -46,720 | -30,420 | -12,490 |